University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 1B-08-2


 
Description: A Multi-Center Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab.
Status: Open
Randomized? Yes


Researchers  
Principal InvestigatorTitle
Christy RussellM.D.

Data Management
NameTitle
Joanne SakamotoR.N.
Gamaliel JacintoD.M.
Yvonne FloresD.M.
Jessica LevanoR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.